CN104027631A - Traditional Chinese medicine preparation for treating liver depression and phlegm stagnation type cholecystitis - Google Patents

Traditional Chinese medicine preparation for treating liver depression and phlegm stagnation type cholecystitis Download PDF

Info

Publication number
CN104027631A
CN104027631A CN201410221487.6A CN201410221487A CN104027631A CN 104027631 A CN104027631 A CN 104027631A CN 201410221487 A CN201410221487 A CN 201410221487A CN 104027631 A CN104027631 A CN 104027631A
Authority
CN
China
Prior art keywords
parts
chinese medicine
herba lysimachiae
radix
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410221487.6A
Other languages
Chinese (zh)
Inventor
陈国明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410221487.6A priority Critical patent/CN104027631A/en
Publication of CN104027631A publication Critical patent/CN104027631A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a traditional Chinese medicine preparation for treating liver depression and phlegm stagnation type cholecystitis. The traditional Chinese medicine preparation is prepared from radix bupleuri, caulis bambusae in taeniam, pericarpium citri reticulatae, ligusticum wallichii, loosestrife, loofah sponge, rhizoma cyperi and madder. The traditional Chinese medicine preparation can be clinically used for treating liver depression and phlegm stagnation type cholecystitis.

Description

A kind of Chinese drugs agentia for the treatment of stagnation of liver-QI expectorant stasis of blood type cholecystitis
Technical field
The invention belongs to technical field of Chinese medicines, especially relate to a kind of Chinese drugs agentia for the treatment of stagnation of liver-QI expectorant stasis of blood type cholecystitis.
Background technology
That chronic cholecystitis refers to is that gallbladder continues, the inflammatory process of outbreak repeatedly, and clinical manifestation is right Upper abdominal pain, or accompanies right shoulder back radiating pain, can accompany the indigestion symptoms such as nauseating, vomiting, belch, acid regurgitation, anorexia be greasy.Draw through inventor's long-term practice, Chinese medicine treating the liver stagnated phlegm stasis of blood type cholecystitis has better effect, obtains good effect.
Summary of the invention
The object of the present invention is to provide the Chinese drugs agentia of the treatment stagnation of liver-QI expectorant stasis of blood type cholecystitis that a kind of therapeutic effect is good, effective percentage is high, human body is had no side effect.
The present invention, according to Chinese medical theory, adopts Radix Bupleuri, Caulis Bambusae In Taenia, Pericarpium Citri Reticulatae, Rhizoma Chuanxiong, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), Retinervus Luffae Fructus, Rhizoma Cyperi, Radix Rubiae according to certain compatibility requirement, through being processed into.
Preparing Chinese drugs agentia of the present invention is made up of following raw material medicaments: Radix Bupleuri 20-40 part, Caulis Bambusae In Taenia 20-40 part, Pericarpium Citri Reticulatae 15-25 part, Rhizoma Chuanxiong 15-25 part, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15-25 part, Retinervus Luffae Fructus 15-25 part, Rhizoma Cyperi 10-20 part, Radix Rubiae 10-20 part.
Optimum weight part of Chinese drugs agentia crude drug of the present invention is: 30 parts of Radix Bupleuri, 30 parts of Caulis Bambusae In Taenia, 20 parts of Pericarpium Citri Reticulataes, 20 parts of Rhizoma Chuanxiongs, 20 parts of Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), 20 parts of Retinervus Luffae Fructuss, 15 parts of Rhizoma Cyperis, 15 parts, Radix Rubiae.
The pharmacological action of Chinese medicine of the present invention is as follows:
Radix Bupleuri: bitter, pungent, be slightly cold, return liver, gallbladder meridian.Evacuation is brought down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI.For stagnation of QI due to depression of the liver, pain in chest and hypochondrium.
Caulis Bambusae In Taenia: sweet, be slightly cold, attach to the lung and stomach meridians.Removing heat-phlegm, relieves restlessness and prevents vomiting.For cough or dysphoria and insomnia due to expectorant heat, gastropyretic vomiting etc.
Pericarpium Citri Reticulatae: acrid, bitter, warm, return spleen, stomach, lung meridian.Regulate the flow of vital energy in tune, stopping nausea and vomiting by lowering the adverse flow of QI, drying dampness to eliminate phlegm.Full vexed for chest and diaphragm, abdominal distention, anorexia, vomiting etc.
Rhizoma Chuanxiong: pungent, warm, return liver, gallbladder, heart channel.Blood-activating and qi-promoting, wind-expelling pain-stopping.For stagnation of QI and blood, rheumatic arthralgia.
Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis): bitter, pungent, flat.Return liver, spleen channel.Clearing away heat-damp and promoting diuresis, promoting blood circulation to remove blood stasis, removing toxicity for eliminating carbuncles.For edema, pyretic stranguria, jaundice, dysentery, rheumatism pyretic arthralgia, leukorrhagia, amenorrhea, traumatic injury, fracture, traumatic hemorrhage, acute mastitis, furuncle, the diseases such as venom.
Retinervus Luffae Fructus: sweet, flat.Return lung, stomach, Liver Channel.Dispelling wind and removing obstruction in the collateral, removing toxic substances is reduced phlegm.For rheumatic arthralgia, the thoracic obstruction, chest and hypochondrium etc.Rhizoma Cyperi: pungent, sweet, micro-hardship, flat.Return liver, tri-jiao channel.Regulate the flow of vital energy resolving depression, regulating menstruation, antiabortive.For distending pain over the hypochondrium, gastral cavity abdomen feeling of fullness pain, abdominal pain during menstruation etc.
Radix Rubiae: bitter, cold.GUIXIN, Liver Channel.Cooling blood for hemostasis, blood circulation promoting and blood stasis dispelling.Clinical in heat in blood spitting of blood, haematemesis, epistaxis, hematuria, has blood in stool, metrorrhagia, amenorrhea, postpartum stagnation stomachache, traumatic injury, rheumatic arthralgia, jaundice, carbuncle sore, hemorrhoid swell and wait disease.
Chinese drugs agentia of the present invention was in 2008 to 2012 clinical observation stagnation of liver-QI expectorant stasis of blood type cholecystitis 69 routine patients, and clinical report is as follows:
1, physical data
In 69 routine patients, age 17-68 year, the course of disease is many at 2 months to 5 years, 46.8 years old mean age.
2, diagnostic criteria
" traditional Chinese medical science disease Standardization of diagnosis and curative effect " that diagnosis basis State Administration of Traditional Chinese Medicine issues:
1. persistence upper right abdomen dull pain or sense of discomfort, or Ban You omoplate district pain; 2. there are the indigestion symptoms such as nauseating, belch, acid regurgitation, abdominal distention and scorching hot, the postemphasis of feed greasy food; 3. the course of disease is long, and the state of an illness has acute attack and alleviates feature alternately; 4. gallbladder area is carved with mild tenderness and is kowtowed pain; 5. in bile, mucus increases, and leukocyte is in heaps, positive bacterial culture; 6. the visible cholelithiasis of ultrasound diagnosis, thickening of capsule wall of gallbladder, gallbladder dwindles or is out of shape; 7. the visible cholelithiasis of cholecystography, gallbladder dwindles or is out of shape, and gallbladder contraction function is bad, or gallbladder develops thin.
Clinical symptoms: it is indefinite that hypochondriac pain is indistinctly walked to alter, connects and also pain of shoulder back, and hypochondriac pain is fixing at nightfall does not move, and happiness is sighed, and personality is suspicious, woman's menoxenia, and xerostomia hardship, purplish tongue gas, stringy and thready pulse, above symptom increases and decreases with feelings will quality.
3, Therapeutic Method
3.1 prescriptions: Radix Bupleuri 30g, Caulis Bambusae In Taenia 30g, Pericarpium Citri Reticulatae 20g, Rhizoma Chuanxiong 20g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 20g, Retinervus Luffae Fructus 20g, Rhizoma Cyperi 15g, Radix Rubiae 15g.
3.2 methods of preparation and use: said medicine routinely technique is made decoction, every day 2 times, 10 days were 1 course for the treatment of at 1 dose of oral every day.
4, therapeutic outcome:
4.1 formulate with reference to " Chinese medicine Clinical Researches of New Drugs guideline ":
Recovery from illness: the primary and secondary syndrome of this syndrome disappears, it is normal that ultrasound diagnosis gallbladder wall and contractile function recover, and gallbladder district pain disappears, and diet, digestion recover normal.Drug withdrawal 3 months is unchanged, follows up a case by regular visits to half a year above without recurrence;
Take a turn for the better: this syndrome primary and secondary syndrome improvement accounts for more than half, and ultrasound diagnosis gallbladder wall and contractile function have clear improvement, and gallbladder district tenderness is clearly better, and diet, digestion are clearly better;
Invalid: through treatment symptom, without alleviation, ultrasound diagnosis gallbladder wall and contractile function are without significant change, and every symptom is not improved.4.2 results: in 69 routine patients, recovery from illness 35 examples (50.7%), 26 examples that take a turn for the better (37.7%), invalid 8 examples (11.6%), total effective rate is 88.4%.
5. model case
5.1 bent certain, female, 39 years old, suffer from cholecystitis 3 years, when pain to the radiation of shoulder back, delayed menstrual cycle, inappetence, appetite reduces, body of the tongue has purple gas, thin lingual fur is slightly yellow greasy, stringy and thready pulse, above symptom increases and decreases with feelings will quality.Take medicine of the present invention, 1 dose of every day, after 2 courses for the treatment of, symptom is clearly better, and continues to take 3 courses for the treatment of, through B ultrasonic check, and gallbladder clear-cut, smooth, size and form is normal, and recovery from illness is followed up a case by regular visits to after 1 year without recurrence.
5.2 Qiu, man, 53 years old.Because upper right abdominal distention and pain once arrived certain hospital therapy, be diagnosed as acute cholecystitis, give intravenous drip levofloxacin, remission.After this often occur right Upper abdominal pain while not relaxing because of the greasy or feelings will of taking food, and to lower back radiation, companion feels sick, vomiting, reaches 2 years.Because occurring upper right abdomen dull pain after feed Carnis Sus domestica, abdominal distention, singultus, vomiting.The light tenderness of upper right abdomen, does not touch gallbladder, Murphy's sign (+).Take medicine of the present invention, treat 2 courses for the treatment of, symptom obviously alleviates, and continues to take 3 courses for the treatment of, and symptom and sign disappears, B ultrasonic check: gallbladder normal in size, wall is smooth, does not visit and stone-echo recovery from illness in capsule, follows up a case by regular visits to without recurrence after half a year.
5.3 grandsons, man, 40 years old.Suffer from cholecystitis 2 years.When medical, hypochondriac pain is indistinctly walked to alter indefinite, connects and also pain of shoulder back, and hypochondriac pain is fixing at nightfall does not move, xerostomia hardship, purplish tongue gas, stringy and thready pulse.Ultrasound diagnosis, cyst wall thickens, and volume increases, and gallbladder wall is rough and coarse.Take medicine of the present invention, treat 2 courses for the treatment of, symptom obviously alleviates, through B ultrasonic check, and gallbladder clear-cut, smooth, size and form normal, continues to take 2 courses for the treatment of, and recovery from illness is followed up a case by regular visits to after half a year without recurrence.
Detailed description of the invention
Embodiment 1, a kind of Chinese drugs agentia for the treatment of stagnation of liver-QI expectorant stasis of blood type cholecystitis, is to be made up of Radix Bupleuri 20g, Caulis Bambusae In Taenia 20g, Pericarpium Citri Reticulatae 15g, Rhizoma Chuanxiong 15g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15g, Retinervus Luffae Fructus 15g, Rhizoma Cyperi 10g, Radix Rubiae 10g.
Embodiment 2, a kind of Chinese drugs agentia for the treatment of stagnation of liver-QI expectorant stasis of blood type cholecystitis, is to be made up of Radix Bupleuri 30g, Caulis Bambusae In Taenia 30g, Pericarpium Citri Reticulatae 20g, Rhizoma Chuanxiong 20g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 20g, Retinervus Luffae Fructus 20g, Rhizoma Cyperi 15g, Radix Rubiae 15g.
Embodiment 3, a kind of Chinese drugs agentia for the treatment of stagnation of liver-QI expectorant stasis of blood type cholecystitis, is to be made up of Radix Bupleuri 40g, Caulis Bambusae In Taenia 40g, Pericarpium Citri Reticulatae 25g, Rhizoma Chuanxiong 25g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 25g, Retinervus Luffae Fructus 25g, Rhizoma Cyperi 20g, Radix Rubiae 20g.

Claims (2)

1. treat a Chinese drugs agentia for stagnation of liver-QI expectorant stasis of blood type cholecystitis, it is characterized in that it is to be made up of following raw material medicaments:
Radix Bupleuri 20-40 part, Caulis Bambusae In Taenia 20-40 part, Pericarpium Citri Reticulatae 15-25 part, Rhizoma Chuanxiong 15-25 part, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15-25 part, Retinervus Luffae Fructus 15-25 part, Rhizoma Cyperi 10-20 part, Radix Rubiae 10-20 part.
2. Chinese drugs agentia according to claim 1, is characterized in that it is to be made up of following raw material medicaments:
30 parts of Radix Bupleuri, 30 parts of Caulis Bambusae In Taenia, 20 parts of Pericarpium Citri Reticulataes, 20 parts of Rhizoma Chuanxiongs, 20 parts of Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), 20 parts of Retinervus Luffae Fructuss, 15 parts of Rhizoma Cyperis, 15 parts, Radix Rubiae.
CN201410221487.6A 2014-05-19 2014-05-19 Traditional Chinese medicine preparation for treating liver depression and phlegm stagnation type cholecystitis Pending CN104027631A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410221487.6A CN104027631A (en) 2014-05-19 2014-05-19 Traditional Chinese medicine preparation for treating liver depression and phlegm stagnation type cholecystitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410221487.6A CN104027631A (en) 2014-05-19 2014-05-19 Traditional Chinese medicine preparation for treating liver depression and phlegm stagnation type cholecystitis

Publications (1)

Publication Number Publication Date
CN104027631A true CN104027631A (en) 2014-09-10

Family

ID=51458776

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410221487.6A Pending CN104027631A (en) 2014-05-19 2014-05-19 Traditional Chinese medicine preparation for treating liver depression and phlegm stagnation type cholecystitis

Country Status (1)

Country Link
CN (1) CN104027631A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105213465A (en) * 2015-10-13 2016-01-06 六盘水永洋生态科技有限公司 A kind of medicine for the treatment of cholecystitis and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105213465A (en) * 2015-10-13 2016-01-06 六盘水永洋生态科技有限公司 A kind of medicine for the treatment of cholecystitis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102872359B (en) Traditional Chinese medicine composition for treating chronic cholecystitis
CN103417790A (en) Traditional Chinese medicine for treatment of cerebral hemorrhage
CN103520531B (en) Traditional Chinese medicinal composition for treating liver depression and qi stagnation type cholecystitis
CN102188638A (en) Medicament for treating liver cancer
CN102872362B (en) Traditional Chinese medicine for treating chronic cholecystitis
CN103251888A (en) Chinese medicine composition for treating depression
CN103495061B (en) Traditional Chinese medicine composition for treating cholecystitis caused by stagnation of liver qi and phlegm and blood stasis
CN102824445A (en) Traditional Chinese medicine composition for treating duodenal ulcer
CN103860896A (en) Medicament for treating chronic obstructive emphysema
CN103479884B (en) Traditional Chinese medicine composition for treating cholecystitis caused by liver-kidney yin deficiency
CN104721407A (en) Traditional Chinese medicine composition for treating liver-depression and qi-stagnation type cholecystitis
CN104027631A (en) Traditional Chinese medicine preparation for treating liver depression and phlegm stagnation type cholecystitis
CN103893321B (en) A kind of Chinese medicine for the treatment of facial spasm
CN102139032A (en) Traditional Chinese medicine for treating intervertebral disc protrusion, hyperosteogeny and rheumatoid disease
CN103520637B (en) Traditional Chinese medicine composition for treatment of dampness and heat accumulation type cholecystitis
CN103536790A (en) Traditional Chinese medicine for treating acute icteric hepatitis
CN103536851A (en) Traditional Chinese medicine composition for treating alcoholic fatty liver
CN102973899B (en) Traditional Chinese medicine composition for treating cholelithiasis
CN102205071B (en) Chinese medicinal composition for treating thyroid cyst
CN104027520A (en) Traditional Chinese medicine for treating liver-qi stagnation type cholecystitis
CN105213655A (en) A kind of Chinese medicine composition of adjuvant treatment of acute cholecystitis
CN103301316B (en) Traditional Chinese medicine composition for treating Intermin-gled phlegm and blood stasis syndrome globus hystericus
CN103405625A (en) Chinese medicine composition for treating hyperplasia of mammary glands
CN104083733A (en) Traditional Chinese medicine preparation for cold-type children's bronchitis
CN103705770A (en) Traditional Chinese medicine for treating rubella

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140910

WD01 Invention patent application deemed withdrawn after publication